David P. Visco,MD, FCCP


Medical Director, Hospitalist Program & Sleep Medicine, CTCA Philadelphia

David P. Visco - Chief, CTCA Division of Hospital Medicine

The people I have worked with at Cancer Treatment Centers of America® are by far the best group I have ever worked with in my career. I look forward to coming to work each day. I am truly blessed to be a part of the team here delivering care to our special patients. I cannot see myself ever working anywhere else.

CTCA Philadelphia
Hospital Medicine
Medical school:
Ross University School of Medicine, Dominica, West Indies
Internal Medicine - Drexel University College of Medicine, Hahnemann University Hospital, Philadelphia, PA
Pulmonary & Critical Care Medicine - Drexel University College of Medicine, Philadelphia, PA

Pulmonary Disease, Critical Care Medicine, Sleep Medicine and Internal Medicine - American Board of Internal Medicine
Diplomate, American Board of Internal Medicine
Fellow, American College of Chest Physicians

Having had a family member touched by cancer, Dr. David Visco, Medical Director of the Hospitalist Program & Medical Director of Sleep Medicine at Cancer Treatment Centers of America® (CTCA), Philadelphia, understands all too well the cancer patient’s journey. That's why he says his overall goal for patients is “to provide hope, compassion and empathy. I view all our patients as family.”

A Diplomate of the American Board of Internal Medicine, Dr. Visco is board certified in pulmonary disease, critical care medicine, sleep medicine and internal medicine

A native of Philadelphia, Dr. Visco earned a bachelor’s degree from Temple University. He earned a medical degree from Ross University School of Medicine and completed an internship in the Department of Internal Medicine at MCP Hahnemann University in Philadelphia.

After medical school, Dr. Visco completed a two-year residency in internal medicine, followed by a three-year fellowship in pulmonary and critical care medicine, at Drexel University College of Medicine in Philadelphia.

In the second year of his residency, Dr. Visco earned the Outstanding Resident of the Year Award. During his fellowship, he was distinguished as Chief Fellow in the Division of Pulmonary and Critical Care Medicine.

Prior to joining CTCA, Dr. Visco worked in the Department of Pulmonary Medicine at Fox Chase Cancer Center in Philadelphia. He also worked in the Department of Medicine at Hahnemann University Hospital, where he served as Performance Improvement Committee Member.

While at Hahnemann, Dr. Visco participated in numerous educational symposiums in critical care. At Drexel, Dr. Visco conducted research on topics including the prevention of bacterial colonization on central venous catheters, the treatment of nosocomial pneumonia and the efficacy of TAK-242 in adults with severe sepsis. He now serves as a Adjunct Clinical Associate Professor of Medicine at Drexel.

In August 2008, Dr. Visco joined the Department of Medical Oncology at Eastern as an internist, pulmonologist and critical care specialist. Since joining, he says he appreciates the unique model of care offered at CTCA: “CTCA provides patients and families from all different parts of our country with the opportunity to empower hope and healing. From my experience, this integrative model is no where else to be found.”

Each day, Dr. Visco says he and the rest of the medical oncology team collaborate with the other clinical areas to provide whole-person, patient-centered care for patients. It’s a team approach to cancer care.

Dr. Visco is a member of several professional organizations, including the American Medical Association, American College of Physicians, Society of Critical Care Medicine, Laennec Society of Philadelphia (Philadelphia Regional Pulmonary Society) and American College of Chest Physicians. He is also a member of the La Valle Del Volturno Club in Philadelphia.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.